Olympus Invests in Israeli Medical Device Company, Medi-TateEnhancement of Competitiveness for Urology Portfolio
November 2, 2018
Olympus Corporation (Representative Director and President: Hiroyuki Sasa) announced today that it has entered into a final agreement for an investment in the Israeli company, Medi-Tate. The agreement includes the right to distribute the company’s products and a call option that, if exercised, would allow Olympus to acquire 100% of the company.
Press releases are company announcements that are directed at the news media.
Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.